AVGO
88
27
KEY
31
2
PNR
66
-3
AAL
59
-4
GME
54
-3
MCHP
43
6
K
50
-3
EW
53
-2
KMX
66
-2
XRAY
47
-2
VTR
43
-3
JPM
59
-3
DVA
63
-2
PGR
59
5
LYB
25
-14
DRI
48
3
GLW
42
-3
TDC
81
5
EQIX
60
-3
AIV
65
-6
AVGO
88
27
KEY
31
2
PNR
66
-3
AAL
59
-4
GME
54
-3
MCHP
43
6
K
50
-3
EW
53
-2
KMX
66
-2
XRAY
47
-2
VTR
43
-3
JPM
59
-3
DVA
63
-2
PGR
59
5
LYB
25
-14
DRI
48
3
GLW
42
-3
TDC
81
5
EQIX
60
-3
AIV
65
-6
Financhill
Back

AddLife AB 10K Form

Sell
49

ADDLF
AddLife AB

Last Price:
42.00
Seasonality Move:
4.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADDLF News And Ratings

See the #1 stock for the next 7 days that we like better than ADDLF

ADDLF Financial Statistics

Sales & Book Value

Annual Sales: $914.78M
Cash Flow: $13.96M
Price / Cash Flow: 60.77
Annual Sales: $4.17
Price / Book: 10.07

Profitability

EPS (TTM): 0.09270
Net Income (TTM): $11.18M
Gross Margin: $339.94M
Return on Equity: 2.29%
Return on Assets: 0.9%

AddLife AB Earnings Forecast

Key AddLife AB Financial Ratios

  • The Gross Profit Margin over the past 11 years for ADDLF is 37.16%.
  • The Selling, General & Administrative Expenses for ADDLF have been equal to 31.66% of Gross Profit Margin.
  • The Research & Development expenses have been 1.72% of Revenue.
  • The Interest Expense is 145.26% of Operating Income.
  • The Net Earning history of ADDLF is 1.96% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 6 years.

AddLife AB Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: ADDLF
Website: add.life

Debt

Debt-to-Equity Ratio: 1.06
Current Ratio: 1.18
Quick Ratio: 0.64

Price-to-Earnings

Trailing P/E Ratio: 285.04
Forward P/E Ratio: 0

ADDLF Technical Analysis vs Fundamental Analysis

Sell
49
AddLife AB (ADDLF) is a Sell

Is AddLife AB a Buy or a Sell?

  • AddLife AB stock is rated a Sell
    The current AddLife AB [ADDLF] share price is $42.00. The Score for ADDLF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.